survey

Download the application

Yao Ming Online

Yao Ming Online

Post from snowball 07-25 15:36.

Today, Fangyi Bio is officially listed in science and technology innovation board.

Yao Ming online snowball column.

On July 25th, Fangyi Bio was officially listed on the Science and Technology Innovation Board of Shanghai Stock Exchange. Fang Bio is an innovative drug research and development company, focusing on major diseases such as tumors and metabolic diseases. At present, there are three core products in the clinical trial stage. According to public information, the funds raised by Fangyi Bio IPO will be mainly used for new drug research and development projects and headquarters base construction projects.

Screenshot source: References [1]

Fang Bio was founded by Dr. Lin and other doctors, 20 13. On average, R &；; The core research and development is to manage the research and development of new drugs; D has more than 20 years of rich team management experience in global pharmaceutical companies. Previously, the company has obtained several rounds of financing, with investors including Gaoying Venture Capital, Qiming Venture Capital, Shanghai Investment Bank, CMB International, Aobo Asia, Lilly Asia Fund, Sinopharm Capital, Jingwei China, etc. At present, there are 3 core products and 5 preclinical research projects in the company's product pipeline, and 1 products have been authorized. Below, we will introduce some selected products.